Literature DB >> 25704591

Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditions.

C Painsi1,2, M Patscheider1, M Inzinger2, R Huegel1, B Lange-Asschenfeldt1,3, F Quehenberger4, P Wolf2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25704591     DOI： 10.1111/bjd.13744

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  3 in total

1.  Induction of IL-1β and antimicrobial peptides as a potential mechanism for topical dithranol.

Authors:  Theresa Benezeder; Ahmed Gehad; VijayKumar Patra; Rachael Clark; Peter Wolf
Journal:  Exp Dermatol       Date:  2021-02-25       Impact factor: 3.960

2.  Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis.

Authors:  Theresa Benezeder; Clemens Painsi; VijayKumar Patra; Saptaswa Dey; Martin Holcmann; Bernhard Lange-Asschenfeldt; Maria Sibilia; Peter Wolf
Journal:  Elife       Date:  2020-06-02       Impact factor: 8.140

Review 3.  Resolution of plaque-type psoriasis: what is left behind (and reinitiates the disease).

Authors:  Theresa Benezeder; Peter Wolf
Journal:  Semin Immunopathol       Date:  2019-10-31       Impact factor: 9.623
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.